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Abstract
Background—Longitudinal studies of cognitive performance are sensitive to dropout, as 
participants experiencing cognitive deficits are less likely to attend study visits, which may bias 
estimated associations between exposures of interest and cognitive decline. Multiple imputation is 
a powerful tool for handling missing data, however its use for missing cognitive outcome measures 
in longitudinal analyses remains limited.
Methods—We use multiple imputation by chained equations (MICE) to impute cognitive 
performance scores of participants who did not attend the 2011-2013 exam of the Atherosclerosis 
Risk in Communities Study. We examined the validity of imputed scores using observed and 
simulated data under varying assumptions. We examined differences in the estimated association 
between diabetes at baseline and 20-year cognitive decline with and without imputed values. 
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Lastly, we discuss how different analytic methods (mixed models and models fit using generalized 
estimate equations) and choice of for whom to impute result in different estimands.
Results—Validation using observed data showed MICE produced unbiased imputations. 
Simulations showed a substantial reduction in the bias of the 20-year association between diabetes 
and cognitive decline comparing MICE (3-4% bias) to analyses of available data only (16-23% 
bias) in a construct where missingness was strongly informative but realistic. Associations 
between diabetes and 20-year cognitive decline were substantially stronger with MICE than in 
available-case analyses.
Conclusions—Our study suggests when informative data are available for non-examined 
participants, MICE can be an effective tool for imputing cognitive performance and improving 
assessment of cognitive decline, though careful thought should be given to target imputation 
population and analytic model chosen, as they may yield different estimands.
Keywords
bias; cognitive function; epidemiologic methods; missing data; multiple imputation; prospective 
study
Introduction
Missing data is common in epidemiologic studies. In longitudinal studies, the focus is often 
on how a baseline exposure is associated with changes in an outcome. Since participants 
who do not attend subsequent study visits are likely informatively different from those who 
do attend, associations may be biased if missing data are not handled appropriately.
Multiple imputation is a powerful tool for dealing with missing data1–4. However, use of 
imputation for cognitive outcome studies remains limited5,6, perhaps because other methods 
are effective for correcting potential biases. For example, maximum likelihood methods, 
routinely used in fitting mixed models, account for biases when missingness is random with 
respect to variables included in primary analyses7. Inverse probability of attrition weighting 
methods and shared parameter models8–11 are also used to address biases associated with 
dropout and death and may incorporate additional variables not included in primary 
analyses.
Multiple imputation is particularly useful when data are available for at least a subset of 
participants who did not attend all study visits, such as participants with low cognitive 
performance who are typically less likely to attend follow-up examinations12–15. Large 
epidemiologic studies with repeat examinations often collect such data through morbidity 
and mortality surveillance or follow-up telephone calls, and may identify participants 
believed to have cognitive impairment. When such data are also collected for individuals 
who attend study visits, multiple imputation may be particularly useful in addressing 
potential biases compared to other analytical methods, and may be a useful tool for 
translating this auxiliary information into a cognitive battery score. substantially informative 
but where auxiliary variables, which are strongly correlated to the dropout and longitudinal 
processes, can be utilized to make model assumptions about missingness more plausible.
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In this study we aimed to document the utility of multiple imputation to address data 
incompleteness in settings where dropout may be substantially informative but where 
auxiliary data were collected to bridge information obtained from fully and partially 
followed individuals. These auxiliary data are not confounders (rather, alternative measures 
of cognitive function), and cannot readily be included in analytic models. However these 
data lend themselves well to inclusion in multiple imputation procedures, allowing for 
unbiased estimates of associations of interest if all variables relevant to dropout are included 
in the imputation, making assumptions about missingness more plausible. To illustrate the 
utility of multiple imputation using chained equations (MICE)2,16 to address missing data, 
we present a case study implementing MICE in a complex situation: estimating the 
association between diabetes at baseline (exposure) and cognitive performance (the 
outcome, measured three times over 20 years of follow-up). Specifically, we show analytic 
findings, and evaluate their robustness, based on imputing cognitive performance scores of 
participants from the Atherosclerosis Risk in Communities (ARIC) Study who did not attend 
the 2011-2013 exam. We also evaluate the utility of MICE in a simulation study generating 
data under different assumptions regarding dropout mechanisms, and show that the accuracy 
of imputation improves with the use of auxiliary information. Finally, using multiple 
imputation in longitudinal analyses compared to cross-sectional analyses presents unique 
issues, such as for whom to impute and the choice of an analytic model, which can affect the 
inferences and target estimands. There is considerable debate in the literature regarding 
accounting for attrition due to death17, and our study documents how choice of analytic 
method and for whom to impute can impact estimates of interest.
Methods
Study population
ARIC is a community-based, prospective cohort of 15,792 middle-aged adults from four 
communities in Maryland, Minnesota, Mississippi, and North Carolina18. Participants were 
examined at four triennial visits, beginning in 1987-1989. A fifth examination occurred in 
2011-2013. Participants in North Carolina and Mississippi also had cognitive assessment at 
Brain and Carotid MRI visits (2004-2006, N=2790). Baseline for the present study was visit 
2 in 1990-1992 (where cognitive assessment began); we excluded participants who did not 
attend baseline (N=1444) or who were neither black nor white (N=91). Institutional review 
boards from each center approved the study, and all participants provided informed consent.
Diabetes assessment
Diabetes at visit 2 was defined as self-reported physician diagnosis, diabetes medication use, 
or a hemoglobin A1c level ≥6.5%.
Cognitive sssessment at study visits
Cognitive function was assessed at visits 2, 4, and 5 using 3 tests: Delayed Word Recall19, 
Digit Symbol Substitution20, and Word Fluency21. We standardized each test score to visit 2 
by subtracting the test mean (at visit 2) from each participant's score and dividing by the test 
standard deviation (SD, at visit 2). A global Z score, calculated by averaging the Z score of 
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the three tests, was likewise standardized to visit 2. The global Z score was the outcome of 
interest and the focus of the imputation.
Auxiliary measures of cognitive function
Information about cognitive function for participants who did not attend visit 5 was available 
through the modified Telephone Interview for Cognitive Status (TICS-m) questionnaire, 
suspect dementia status, and the Clinical Dementia Rating (CDR) scale.
The TICS-m, a test of cognitive function given over the telephone22–24, was offered to all 
participants who did not attend visit 5 (completed for N=1327), and to a random subsample 
of participants who attended visit 5 (N=255).
Participants were classified as having suspect dementia based on information obtained by 
telephone with the participant or their proxy, or an ICD-9 code of dementia appearing in any 
position in hospital discharge records25 (N=1462). If participants with suspect dementia did 
not complete visit 5 or the TICS-M, their proxies were sought to complete a CDR. Suspect 
dementia status was available for all participants in ARIC.
For participants with suspect dementia, interviews were sought with proxy informants. The 
CDR was completed by telephone with informants familiar with the participant's current 
cognitive status (for living participants) or cognitive status 12 months prior to death. It 
covers six domains (memory, orientation, judgment and problem solving, community affairs, 
home and hobbies, and personal care). For deceased participants, interviewers were carefully 
instructed to focus on change in cognitive status occurring 12 or more months prior to death, 
and to avoid reports of pre-terminal cognitive decline. Considering difficulties in attempting 
to reach proxies of participants who died more than 10 years prior to visit 5 and that few 
participants would be expected to have dementia prior to this date (mean age was 70), a 
CDR was sought only for participants who died after 2004.
Interviewers scored each of the six domains using a scale of 0 (no impairment), 0.5 
(questionable), 1 (mild), 2 (moderate), and 3 (severe impairment). The CDR sum of boxes 
(total score) ranged from 0 to 18. The CDR was collected on 885 participants who did not 
attend visit 5 (N=575 with suspect dementia) and from 2856 who attended visit 5 (N=176 
with suspect dementia).
Diabetes association with cognitive decline over 20 years
To examine the association between diabetes and cognitive change over 20 years, we 
considered two modeling strategies: mixed-effects models and models fit using generalized 
estimating equations (GEE). Time since baseline (visit 2) was modeled using a linear spline 
with a knot at six years (median time to visit 4). Our mixed models included one random 
intercept and a random slope for each time spline term, with random effects assumed to be 
independent. The coefficients of interest were the interaction terms between diabetes and 
each time spline term, which indicate differential decline over time among persons with 
diabetes at baseline compared to those without. A limitation of the mixed model approach is 
that there is implicit imputation of cognitive scores beyond death (via the random effects), 
resulting in inferences to an immortal cohort26. While such an estimand may be of interest, 
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we also applied models fit using GEE and independent working correlation with robust 
variance estimation. Using GEE with independent working correlation avoids the potentially 
undesired implicit imputation effect when participants' data are missing.
The different analytic strategies (mixed and GEE), combined with the persons for whom we 
impute (no imputation, imputation for living, or imputation for living and deceased 
participants), give rise to different estimands, which should be carefully considered when 
choosing an imputation and analysis strategy. For this study we focus on three analyses: 1) 
using MICE to impute missing participants' scores (living and deceased) and estimating 
associations of interest using a mixed model with random intercept and slopes, 2) using 
MICE to impute missing participants' scores (living and deceased) and estimating 
associations of interest using GEE with independent working correlation, and 3) restricting 
the population to 20-year survivors, using MICE to impute scores for participants living at 
visit 5, and conducting analyses using both mixed models and GEE. The first analysis infers 
the findings to be expected if those dying had remained alive subsequently, continuing on 
their trajectory while living. The second targets the population average association between 
diabetes and cognitive decline while participants were alive. The last targets the population 
average association conditional on participants surviving 20 years. Lastly, we compare 
results from these analyses to those obtained without the use of imputation and for 1) and 2) 
above, to those using imputation only for participants living to visit 5, where the deceased 
contribute data only while living.
All models were adjusted for demographic, behavioral, and cardiovascular risk factors as 
have been previously used27 (See Figure 2 legend).
Multiple imputation
Missing data can be classified as follows28,29: missing completely at random (MCAR) when 
missingness does not depend on either observed or unobserved data; missing at random 
(MAR) when, after conditioning on observed data, missingness does not depend on 
unobserved data; or missing not at random (MNAR), when missingness depends on 
unobserved data (such as unmeasured dementia status).
Multiple imputation replaces missing data with plausible values, and has been demonstrated 
to produce asymptotically unbiased estimates when missing data are MAR or MCAR2,30. To 
account for the uncertainty of the imputation and ensure correct standard error estimation, 
multiple imputations are performed28. Multiple imputation by chained equations (MICE) 
involves a series of imputation models, where each variable containing missing data is 
regressed on all other variables, including previously imputed missing variables2,16,30,31. 
The flexibility of MICE to impute different data types (categorical, continuous, binary, etc) 
makes it an attractive tool for use in practice. We used 25 sets of imputations, although we 
observed stability in estimates after 6-7 imputations (eFigure1). For participants alive at visit 
5, scores were imputed at the median visit date. For participants who were deceased by visit 
5, scores were imputed 6 months prior to death. In analyses using imputation for the living 
and deceased, all records with imputed values were retained. In analyses conditional on 
survival, all records after a participant was deceased were dropped from the dataset. In 
analyses conditional on survival to visit 5, all records of persons who died during follow-up 
Rawlings et al. Page 5
Eur J Epidemiol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
were dropped from the dataset. After using MICE to impute cognitive performance scores, 
we estimated the association of diabetes with 20-year cognitive change, using mixed models 
and models fit using GEE as described above, by conducting analyses separately on each 
imputed dataset, and combining the estimated coefficients and standard errors from each 
analysis using Rubin's rules4. In both the mixed model and GEE analyses, outcome means 
were modeled with a linear link and were related to time by a spline model as described 
above.
The imputation model for global Z score at visit 5 included the same variables as the mixed-
effects longitudinal model (described above) as well as variables collected from annual 
telephone calls, TICS-M, suspect dementia status, CDRs, and global Z scores from visits 2 
and 4. From the annual telephone call most nearly preceding visit 5 we included the 
following variables (all coded yes/no): coronary heart disease, diabetes status, hypertension 
status, history of stroke, self-reported poor health, and an indicator of whether a proxy report 
was needed. We selected these variables a priori based on knowledge of their association 
with probability of dropout and cognitive function. Interaction terms between suspect 
dementia and education, race-field center, prior visit Z scores, CDR, diabetes, and 
hypertension were also included. Interaction terms were needed because suspect dementia 
modified outcome relationships with prior cognitive performance and other covariates. For 
example, if a person with suspect dementia was found by CDR to have severe impairments, 
cognitive performance at an earlier exam may be less informative relative to current 
performance. We included variables for time since baseline as a basis for timing imputation 
of visit 4 and visit 5 scores. Additionally, we examined whether an indicator for death 
modified the relationship between covariates and cognitive function by including interaction 
terms between the death indicator and other covariates or interest (CDR, prior Z scores, 
suspect dementia, and diabetes). These interactions were not significant and were not 
included in the final imputation model. We examined including other visit-based variables 
from clinical chemistries, medical/health history, anthropometry, and medication survey. 
Since these additional variables did not improve the imputation or change the results of 
longitudinal analyses using these imputations, they were not used in the analyses reported 
here.
Lastly, we compared imputed values with and without the use of auxiliary information to 
gauge the improvement in imputation with the use of this data. While few participants with 
suspect dementia came to visit 5, auxiliary information in this group would be most 
informative for imputing scores.
Validation and simulation
We used two validation approaches. First, we set to missing cognitive scores of a random 
sample of participants who attended visit 5, and then compared imputed with observed 
values. To validate imputations under an MCAR missingness assumption among participants 
alive at visit 5, we randomly selected 20% of participants and set their Z score to missing; to 
validate under a MAR missingness assumption, we used a logit model to allow the 
probability of missingness to differ by the following baseline variables: age, race-center, 
education, diabetes, global Z from visit 2, and diabetes*global Z from visit 2. Because none 
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of the persons who died attended visit 5, we could not use the same approach to validate 
cognitive Z scores for the deceased. As an alternative, we used Z scores obtained from 
participants who attended the Brain or Carotid MRI visits (2004-2006). Scores for 
participants who died are imputed across a wider time range (2004-2013). To obtain 
observed Z scores proximal to when Z scores for the deceased were imputed, we conducted 
our validation analysis for deceased participants by comparing the observed Z scores from 
the 2004-2006 visits to imputed scores in those who died within two years of the Brain or 
Carotid MRI visit. The 2004-2006 data were used only for validation, and were not used in 
the imputation model.
As a second validation approach, we evaluated the performance of MICE using a simulation 
study addressing patterns of missingness corresponding to MCAR, MAR, and MNAR. We 
retained the observed values of all covariates for individuals from the ARIC population and 
simulated Z scores using a mixed-effects model that included age, race-field center, sex, 
body mass index, suspect dementia, diabetes, hypertension, and interaction terms suspect 
dementia*time, hypertension*time, current cigarette smoking*time, and diabetes*time, 
modeling time using spline terms (described above). Including suspect dementia was 
necessary to allow us to retain the correlations between risk factors and cognitive decline. 
Additionally, CDR data were specifically sought for persons with suspect dementia, so 
including it was necessary in generating “believable” Z scores. Using this model, persons 
with hypertension, diabetes, or smokers, by design, had accelerated cognitive decline. 
Coefficients of each variable and the random-effects parameters were chosen to be similar to 
values estimated from the cohort (these were estimated by fitting this same model using 
observed ARIC data). Simulation specifications are detailed in the Appendix.
To model probabilities of dropout and death, we created four scenarios reflecting different 
dropout mechanisms. Scenario 1 (MCAR) assumed death and dropout occurred completely 
at random. Scenario 2 (MAR) assumed the probabilities of death and dropout (separately) 
depended on prior visit global Z score, diabetes, hypertension, and smoking status modeled 
using a multinomial logistic regression. These variables are included in our analytic model 
and hence result in a MAR scenario. Scenario 3 (MAR for the variables included in the 
imputation, MNAR for variables included in primary analyses) assumed the probabilities of 
death and dropout depended on prior visit global Z score (visit 2 and 4), diabetes, 
hypertension, smoking status, suspect dementia, and a diabetes*suspect dementia interaction 
(suspect dementia collected around visit 5). In this scenario, the variables suspect dementia 
and its interaction with diabetes are included in the MICE to impute scores, but are not 
included in our analytic model, resulting in MAR and MNAR for MICE and our analytic 
model, respectively. Scenario 3 is most consistent with what we believe the true missingness 
pattern in ARIC to be. Scenario 4 (MNAR) assumed that dropout depended only on 
simulated visit 5 global Z scores (i.e. unobserved scores), and that death among dropouts 
was random with a probability of 0.4. For each scenario, we analyzed data using available-
case analysis, MICE restricted to participants living at the time of visit 5, and MICE 
including both living and dead participants. Estimates for all scenarios were obtained using 
both mixed-effects modeling and using GEE with independent correlation structure. We also 
calculated standard errors, bias, and confidence interval (CI) coverage (the percentage of 
simulations where the true association was contained in the 95% CI). Bias was calculated 
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both relative to a trajectory-among-those-living-for-visits and to a trajectory-up-to-death. 
The “truth” trajectories were estimated using the same models described above (mixed/GEE) 
in these simulated data prior to implementing the dropout or death scenarios (i.e. prior to 
creating the missing data).
For both validation approaches, MICE was used to perform imputation, and the longitudinal 
analyses were conducted using linear-link mixed models or linear-link models fit with GEE. 
Analyses were completed using Stata/SE Version 13.1 (StataCorp, College Station, TX).
Results
Of the original visit 2 cohort, 55% did not attend visit 5, with approximately equal 
percentages due to death (29%) and dropout but living prior to visit 5 (26%); these values 
also represent the percentages of the original visit 2 cohort for which imputation was 
performed. Comparatively, 16% of the visit 2 cohort did not attend visit 4 (but were living) 
and 3.8% were deceased by visit 4 (eTable 1). Compared to participants who attended visit 
5, participants who died by visit 5 tended to be older at baseline (age 60 vs 55 years), were 
more likely to have diabetes (24% vs 8%) and a history of stroke (4% vs 1%), and had worse 
baseline cognitive performance (Table 1). Additionally, 15% of the deceased were suspected 
of having dementia, compared to only 4% among participants who attended visit 5.
Validation results based on observed data are shown in Figure 1. MICE produced unbiased 
imputed values regardless of whether an MCAR or a MAR approach was used to select the 
validation sample (Figure 1, Panels A and B). Additionally, imputed values were unbiased 
in subgroups defined by race, education, diabetes, cognitive performance at visit 4, and 
suspect dementia (not shown). Among both MCAR and MAR validation samples, and by 
these subgroups, mean differences between imputed and observed global Z ranged from 
-0.03 to +0.02 Z scores, and the r-squared from a linear fit model between observed and 
average imputed scores ranged from 0.65 to 0.68. As shown in Figure 1, Panel C, among 74 
participants who died less than 2 years after attending the Brain or Carotid MRI visits, 
agreement between the imputed and observed global Z scores was excellent. The mean 
difference was -0.02 Z scores, and the r-squared was 0.70 from the linear fit model where 
observations were weighted relative to time since the brain or carotid visit (calculated as 1/
time, such that deaths closer to the visit received higher weights). Finally, Figure 1, Panel D 
shows the distribution of imputed scores at visit 5, by CDR availability, among persons with 
suspect dementia. The characteristics of participants without a CDR were similar to those 
with a CDR (eTable 2). However, because the informant could not be located (and CDRs 
were not obtained), the average imputed scores were higher by 0.55 Z scores than the 
average imputed score for participants whose informant was interviewed. This result implies 
that when a CDR could not be obtained, we had insufficient information with which to 
impute a plausibly low enough cognitive score. Using the auxiliary information on cognitive 
function in MICE resulted in a higher r-squared, lower root mean squared error, and lower 
imputed scores among participants with suspect dementia, compared to MICE without the 
auxiliary information (eFigures 2 and 3).
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Simulation results are in Table 2. When data were MCAR (scenario 1) or MAR (scenario 2), 
all methods yielded approximately unbiased estimates, as expected. In scenario 3, where 
dropout depended on suspect dementia, available-case analysis (i.e. no imputation) using 
mixed models yielded a 16% bias, which was reduced to 4% with imputation for living 
participants, and a reduction from 23% to 3% with imputation for living and deceased. We 
observed similar trends for scenario 3 using GEE, with a 33% bias reduced to 2% with 
imputation in the living, and a 55% bias reduced to 10% with imputation in living and 
deceased. We also saw that targeting a trajectory among the living (using GEE) can result in 
an anticonservative bias if the imputation includes living and deceased participants (22% and 
34% anticonservative bias in scenarios 2 and 3). In scenario 4, where participants were 
missing based on their unobserved cognitive function, no method yielded unbiased results 
(bias ≈18-32%).
Estimates of 20-year additional cognitive decline in persons with diabetes compared to those 
without are shown in Figure 2. For both mixed model and model fit with GEE, imputation 
yielded larger estimates of additional decline due to diabetes, compared to available case 
analysis, although confidence intervals overlapped. Mirroring the simulation study, estimates 
of additional decline were consistently smaller for GEE (-0.14 – -0.17 Z) compared to the 
mixed model (-0.21 Z). Estimates across models were nearly identical when we conditioned 
on surviving through the end of follow-up (i.e. restricted analyses to participants who 
survived 20-years).
Discussion
In this community-based cohort study, we used multiple imputation by chained equations to 
impute cognitive performance as the outcome for subsequent epidemiologic questions. 
Validation analyses showed that MICE yielded unbiased imputations of cognitive 
performance for both living and deceased participants, with the exception that the procedure 
may not specify scores plausibly low enough for persons with suspect dementia whose 
informants could not be interviewed. In those believed to have dementia, the use of auxiliary 
information yielded improved imputation of cognitive scores compared to imputation 
without this information. We showed that estimates of the associations of diabetes with 20-
year cognitive decline were substantially further from the null with the use of MICE, 
compared to an available-case analysis. Simulations showed that when data are 
informatively missing and related additional data are available, MICE may produce less 
biased estimates of associations of interest compared to available-case analysis. Lastly, we 
demonstrated changes in estimates depending on for whom we impute (living or living and 
deceased) and with the analytic approach (mixed models or independence GEE).
We note several limitations to our simulation study. First, suspect dementia was built into the 
data-generating model in our simulations but not included as a covariate in subsequent 
mixed models. The need to do so highlights implications of unobserved covariates even in a 
MAR scenario: analyses including only participants living at visits and those also 
incorporating the deceased may target different estimands as a result of the groups' 
differentiation by the unobserved covariate. Second, while we chose parameters for 
simulation models that we believe are realistic (coefficients were obtained from models 
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using observed ARIC data), simulation results depend on assumptions made about the 
generating, death, and dropout models.
We imputed scores for the dead 6 months before death, with attempts made to ignore pre-
terminal changes. However, certain analysis methods, such as mixed-models, may implicitly 
impute cognitive trajectories beyond death, giving inferences for an immortal cohort17,26, 
and we observed an indication of this occurring in our analyses. Such analyses (mixed 
model with imputation for all participants) target an estimand that can be interpreted as the 
20-year population average association had participants remained alive and under 
observation (via study visits or ancillary information). Immortal cohort inferences may be of 
interest as interventions to prolong life continue to improve, and people with cognitive 
impairment live longer32,33, and may also be of particular interest in causal inference. While 
this approach has merits, it also has limitations. Imputations for dead participants are placed 
before death, which can occur along a wide time interval, while imputations for living 
participants are anchored to visits. Thus, the former imputation gives different statistical 
leverage to those who died. One remedy is potentially the use of linear models fit with GEE 
using an independent working correlation matrix. While standard errors need to be carefully 
estimated in this scenario, this approach may be useful when using imputed scores, as it 
would avoid the potentially undesired effect of implicit imputation and inferences for an 
immortal cohort. Such analysis targets an estimand that represents the whole population's 
cognitive natural history up to, but not beyond death, or the population average association 
while living.
Estimating trajectories of cognitive function using data only at clinic visits of living 
participants has the advantage of being directly informed by observations timed 
independently of adverse outcomes. Resulting estimands of cognitive decline among persons 
remaining alive is also relevant as persons with diabetes may be interested in knowing the 
cognitive trajectory they might expect assuming they survive 20 years. This estimand in a 
mortal cohort resulted from restricting the population to survivors, and estimates across 
models (GEE vs mixed) were nearly identical. However, ignoring the stronger association of 
diabetes with cognitive decline in persons who die or drop out due to dementia is likely to 
inadequately represent the natural history of the entire baseline population.
In our mixed model analyses we debated which imputation approach should be prioritized: 
one imputing outcomes for participants lost to follow up due to death (outcomes timed six 
months prior to death), or one imputing outcomes only for living participants. We concluded 
that the former was more consistent with the immortal inference provided by the mixed 
model approach. However we continue to see value for mixed models retaining only 
information while living (whether imputed or not), to address a mortal inference. The latter 
avoids the analytic limitations noted two paragraphs above, as well possibly as conceptual 
ones. Such an analysis may more validly estimate the mean rate of change at a given time 
than the GEE alternative, because it explicitly addresses this estimand (as opposed to 
“population average” differences in means across time for GEE).
The choice of when and for whom we impute the outcome deserves careful thought. While 
our study saw relatively similar results under two imputation scenarios (imputing only for 
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living participants and imputing for living and deceased) and analytic methods (mixed 
model and GEE), others may not. While our study does not settle the more controversial 
question of what approach is preferable for dealing with the potential bias induced when 
attrition is due to death17,34, it adds to the literature in this area. Though guidance regarding 
multiple imputation is available2,16,31,35, less is known about its utilization in epidemiologic 
studies for imputing cognitive outcomes in longitudinal analyses and the analytic issues that 
arise in this setting as we have documented. While methods such as inverse probability 
weighting or likelihood-based approaches are more common36, multiple imputation may be 
ideal for handling missing data when valuable information is available only in a subset of 
participants, as is the case in our and other community-based cohort studies. More research 
is needed to determine if a combined approach using both imputation and inverse probability 
weighting in epidemiologic studies would yield improved estimates37,38.
Advantages of MICE include its flexibility in imputing different data types (e.g. categorical, 
continuous, etc.), and relative ease of implementation using standard statistical packages. A 
disadvantage of MICE may be its atheoretical nature. Specifically, the series of conditional 
models may lead to situations where the joint distributions are incompatible. However 
studies have shown that MICE appears to be generally robust against such 
incompatibility1,30,39. MICE does not necessarily produce unbiased estimates when data are 
missing based on unobserved information; in such scenarios, analyses to explicate sensitivity 
of findings to the strength of non-ignorable associations are optimal40,41. A notable 
disadvantage of MICE is program run time, which required hours to run. Finally, careful 
thought should be given to collection of alternative data to supplement the data collected at 
regular study visits, whether through proxies, phone calls, or other surveillance. We showed 
that this information improved imputation in informative subgroups, and such supplemental 
data are invaluable to characterize and minimize informative missingness, provided that one 
avoids differential information bias.
In summary, our results suggest that when informative data are available for participants 
who do not attend study visits, MICE is an effective tool for imputing cognitive performance 
as the outcome, and may improve assessment of cognitive decline.
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Figure 1. 
Validation of multiply imputed global Z score using existing data, Multiple imputation was 
done using chained equations, and 25 imputations were obtained and averaged for display in 
each plot. Panel A: 20% validation sample to simulate missing completely at random 
(MCAR) data. All participants had a 0.2 probability of being selected. If selected, 
participants' Z scores at visit 5 were set to missing and imputed. Panel B: 20% validation 
sample to simulate missing at random (MAR) data. Participants had varying probabilities of 
selection into the validation sample, with probabilities varying by education (less than high 
school, high school, greater than high school), race (black, white), diabetes (yes, no), or 
global Z score at visit 2 in the bottom 25th percentile (yes, no), and all interactions. If 
selected, participants' Z scores at visit 5 were set to missing and imputed. Panel C: 
Validation of imputed scores for participants who were deceased within 2 years of either the 
brain or carotid MRI visits, which took place 2004-2006 (N=74). Square size is inversely 
related to difference between visit date and death date (i.e. weight=1/time between visits), 
such that larger squares indicate death closer to the time of visit. Linear fit line is weighted 
using the inverse of difference between visit date and death date, and yielded an r-squared of 
0.70. Panel D: Distribution of imputed scores among people with suspected dementia 
(N=1,462) by CDR status, adjusted for vital status (living/deceased).
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Figure 2. Estimated 20-yeae additional decline in cognitive performance for persons with 
diabetes compared to persons without, by model type and use of imputation
Mixed: estimates and 95% CIs are from mixed-effects models using time since baseline as 
the time axis, modeled using a spline term with a knot at 6 years, the median time between 
visits 2 and 4. Random effects were random intercept and two random slopes, one for each 
time spline term.
GEE: estimates and 95% CIs are from models fit using generalized estimating equations 
with independent working correlation and robust variance estimation.
All models were adjusted for age, age squared, race-field center (Maryland (white race); 
Minnesota (white race); North Carolina (white race); North Carolina (black race); 
Mississippi (black race)), sex, education (less than high school; high school, high school 
equivalent, or vocational school; or college, graduate, or professional school), cigarette 
smoking status (current; former; never), alcohol consumption status (current; former; never), 
body mass index (kg/m2), hypertension (yes or no), history of stroke (yes or no), 
apolipoprotein E ε4 genotype (0, 1, or 2 alleles). Interaction terms between the time spline 
terms and age, sex, race-field center, education, history of stroke, and apoliprotein E ε4 
genotype were also included in the model. All covariates were assessed at visit 2 (baseline) 
except education, race, and sex (visit 1). 25 imputations were generated by chained 
equations. Sample sizes for mixed/GEE were as follows: No imputation: 
participants=13482, observations=29616; Imputation of outcome for living participants: 
participants= 14151, observations=37854; imputation of outcome for living and deceased 
participants: participants = 14151, observations = 40019. For analyses conditioned on 20-
year survival they were: No imputation: participants=10039, observations=23445; 
Imputation of outcome for living participants: participants= 10039, observations=30117.
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Abbreviations: GEE, generalized estimating equations.
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Table 1
Participant baseline characteristics by vital status at visit 5
Total Attended visit 5 Alive, did not attend visit 5 Deceased by visit 5
N (%) 14,229 6,340 (45) 3,713 (26) 4,176 (29)
Age 57.0 (5.7) 55.1 (5.2) 57.4 (5.7) 59.8 (5.4)
Female, % 55.4 58.9 61.3 45.0
Black, % 24.7 22.6 22.9 29.5
HbA1c, % 5.8 (1.2) 5.6 (0.9) 5.7 (1.0) 6.2 (1.7)
Diabetes, % 13.6 7.5 12.2 24.2
Body mass index, kg/m2 28.0 (5.4) 27.6 (5.1) 28.1 (5.5) 28.3 (5.8)
History of CHD, % 5.8 2.6 3.9 12.3
History of stroke, % 1.9 0.8 1.2 4.3
Hypertension, % 36.1 27.4 36.3 49.2
APOE e4 alleles, %
 0 69.1 71.1 68.9 66.3
 1 28.2 26.6 28.5 30.5
 2 2.6 2.3 2.6 3.2
Education, %
 Less than high school 21.9 14.7 23.5 31.4
 High school 41.5 41.9 43.7 38.9
 College/vocational 36.6 43.4 32.9 29.7
Smoking, %
 Current 22.4 16.2 21.0 33.1
 Former 37.9 38.5 36.6 38.2
 Never 39.7 45.3 42.4 28.7
Drinking, %
 Current 56.3 60.9 53.8 51.5
 Former 21.2 17.1 21.0 27.6
 Never 22.5 22.0 25.2 20.8
Measures of cognitive function
 Global Z 0.00 (1.00) 0.24 (0.93) -0.01 (0.94) -0.37 (1.04)
 DWRT, words recalled 6.6 (1.5) 6.9 (1.5) 6.6 (1.5) 6.2 (1.6)
 DSST, number completed 44.6 (14.2) 48.1 (13.5) 44.6 (13.4) 39.1 (14.4)
 WFT, words generated 33.2 (12.5) 35.0 (12.2) 32.7 (12.1) 30.8 (12.8)
 Suspected Dementia by Visit 5, % 10.3 4.2 15.6 14.7
 CDR sum of boxes* 2.8 (4.7) 1.3 (2.4) 7.3 (6.8) 8.0 (6.9)
 TICS-M 34.2 (7.4) 34.2 (7.7) 34.2 (7.3) -
Values shown as % or mean (SD). All variables measured at visit 2 (1990-1992) except CDR, which was collect around the time of visit 5 
(2011-2013) via contact with participants or a proxy. Suspected dementia was ascertained prior to visit 5 from hospitalization records with an 
ICD-9 code for dementia or from contact with participants or their proxy where cognitive impairment was indicated.
*Available for a subset of participants, N=3741
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Abbreviations: CHD, coronary heart disease; DWRT, delayed word recall test; DSST, digit symbol substitution test; WFT, word fluency test; CDR, 
clinical dementia rating; TICS-M, modified telephone interview for cognitive status.
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